Xtx Topco LTD Galecto, Inc. Transaction History

Xtx Topco LTD

  • $1.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$0.6 - $0.89 $10,948 - $16,239
18,247 New
18,247 $14,000
Q3 2023

Nov 13, 2023
BUY
$0.56 - $3.17 $9,691 - $54,863
17,307 New
17,307 $12,000
Q3 2021

Nov 12, 2021
SELL
$3.59 - $5.0 $39,554 - $55,090
-11,018 Closed
0 $0
Q2 2021

Aug 12, 2021
BUY
$4.63 - $8.0 $51,013 - $88,144
11,018 New
11,018 $56,000

Others Institutions Holding GLTO

# of Institutions
1
Shares Held
21.2K
Call Options Held
0
Put Options Held
0
View Full List

About Galecto, Inc.

GLTO Quotes by TradingView
  • Ticker GLTO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,395,700
  • Market Cap $143M
  • Description
  • Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clini...
More about GLTO
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email